Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol in the Treatment of Epilepsy
Randi von Wrede, Christoph Helmstaedter, Rainer Surges
Clinical Drug Investigation (2021) Vol. 41, Iss. 3, pp. 211-220
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 204
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 180
The mechanism of microglia-mediated immune inflammation in ischemic stroke and the role of natural botanical components in regulating microglia: A review
Jinsong Zeng, Tingting Bao, Kailin Yang, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 75
Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation
Sahithi Madireddy, Samskruthi Madireddy
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 784-784
Open Access | Times Cited: 43
Toll-like receptor signalling as a cannabinoid target
Melody Cui Sun, Almudena Otálora-Alcaraz, Jack Prenderville, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116082-116082
Open Access | Times Cited: 11
Cannabidiol y epilepsia: avances en su investigación como opción terapéutica
Cecilia Zavala‐Tecuapetla, Ana Canseco-Alba, Joaquín Manjarrez-Marmolejo, et al.
eNeurobiología (2025) Vol. 16, Iss. 40
Open Access | Times Cited: 1
Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review
Kuldeep Singh, Bharat Bhushan, Dilip Kumar Chanchal, et al.
Behavioural Neurology (2023) Vol. 2023, pp. 1-17
Open Access | Times Cited: 21
Determining Antioxidant Activity of Cannabis Leaves Extracts from Different Varieties—Unveiling Nature’s Treasure Trove
Anna Stasiłowicz-Krzemień, Szymon Sip, Piotr Szulc, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1390-1390
Open Access | Times Cited: 18
CBD in the Treatment of Epilepsy
Kinga K. Borowicz-Reutt, Julia Czernia, Marlena Krawczyk
Molecules (2024) Vol. 29, Iss. 9, pp. 1981-1981
Open Access | Times Cited: 6
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models
Emma Puighermanal, Marta Luna‐Sánchez, Alejandro Gella, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long Chi Nguyen, Loubna Oumeslakht, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 23
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Justin Matheson, Zoe Bourgault, Bernard Le Foll
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1462-1462
Open Access | Times Cited: 21
Cannabidiol and epilepsy in Brazil: a current review
Carlos André Oshiro, Luiz Henrique Martins Castro
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 5 suppl 1, pp. 182-192
Open Access | Times Cited: 19
Exploring the therapeutic potential of cannabinoids in cancer by modulating signaling pathways and addressing clinical challenges
Manal Bint Faiz, Faiza Naeem, Muhammad Irfan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Prolonged incubation with Δ9-tetrahydrocannabinol but not with cannabidiol induces synaptic alterations and mitochondrial impairment in immature and mature rat organotypic hippocampal slices
Costanza Mazzantini, Lorenzo Curti, Daniele Lana, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117797-117797
Closed Access
Effects of Cannabidiol on Locomotor Activity
Fabrizio Calapai, Luigi Cardia, Gioacchino Calapai, et al.
Life (2022) Vol. 12, Iss. 5, pp. 652-652
Open Access | Times Cited: 17
Synergistic Attenuation of Combined CBD Oil and Low Dose Valproic Acid in PTZ-Induced Seizure and in-silico Analysis
Abdulaziz K. Al Mouslem, Mohammed Al Mohaini, Faisal Alghamdi, et al.
International Journal of Pharmacology (2025) Vol. 21, Iss. 1, pp. 138-149
Closed Access
Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy
Silvia Kochen, Manuela Villanueva, Liliana Bayarres, et al.
Epilepsy & Behavior (2023) Vol. 144, pp. 109210-109210
Closed Access | Times Cited: 9
Beneficial effects of cannabidiol from Cannabis
Sullim Lee, Yunjeong Lee, Yunseo Kim, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3
Advancements in Drug Repurposing: Examples in Psychiatric Medications
Ryo Okuyama
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11000-11000
Open Access | Times Cited: 7
Cannabidiol modulates hippocampal genes involved in mitochondrial function, ribosome biogenesis, synapse organization, and chromatin modifications
João P. D. Machado, Valéria de Almeida, Antônio Waldo Zuardi, et al.
Acta Neuropsychiatrica (2024) Vol. 36, Iss. 5, pp. 330-336
Closed Access | Times Cited: 2
Off-label use of cannabidiol in genetic epileptic and developmental encephalopathies: A case report
Elisa Mannini, Francesco Misirocchi, Stefania Lazzari, et al.
Epilepsy & Behavior Reports (2024) Vol. 27, pp. 100687-100687
Open Access | Times Cited: 2
Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages
Shallu Tomer, Wenli Mu, Gajendra W. Suryawanshi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Synthesis, characterization and antitumor activity of a poly-4-Vinyl pyridine-co-cannabidiol polymer
David Fuentes‐Ríos, Federico Moya‐Utrera, Javier Moreno, et al.
European Polymer Journal (2024) Vol. 219, pp. 113328-113328
Open Access | Times Cited: 1
Psychiatric comorbidities before and after cannabidiol treatment in adult patients with drug resistant focal epilepsy
Julián Lamonarca, Inés Mintz, Liliana Bayarres, et al.
Epilepsy & Behavior (2024) Vol. 160, pp. 110032-110032
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top